Related Experiment Video
Updated: Aug 12, 2026

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
Published on: February 20, 2019
Collaborative multidisciplinary workshop report: clinical antimicrobial trials for primary and secondary prevention
H Rosen1, J B Muhlestein, J Bartlett
1Department of Medicine, Harborview Medical Center, University of Washington, Seattle, WA, USA.
Abstract:
The task assigned to the working group on Clinical Antimicrobial Trials for Primary and/or Secondary Prevention of Atherosclerotic Cardiovascular Disease was to evaluate the need for additional clinical antibiotic trials of a primary or secondary nature for the treatment of atherosclerotic heart disease and to suggest possible designs for future trials. In addition, the working group was to define the role of collaboration in answering research questions.
Insights
This review assesses the need for more antibiotic trials in preventing atherosclerotic cardiovascular disease. It also proposes future trial designs and emphasizes collaboration in research.
Area of Science:
- Cardiovascular Medicine
- Infectious Diseases
- Clinical Trials
Background:
- Atherosclerotic cardiovascular disease (ASCVD) remains a leading cause of mortality worldwide.
- The role of antimicrobial agents in the primary or secondary prevention of ASCVD is not fully established.
- Existing research has not definitively determined the necessity of further clinical antibiotic trials in this domain.
Purpose of the Study:
- To evaluate the need for additional clinical antibiotic trials focused on the primary and/or secondary prevention of atherosclerotic cardiovascular disease.
- To propose potential designs for future clinical trials investigating antimicrobial interventions for ASCVD.
- To define the significance and structure of collaborative efforts in addressing research questions related to ASCVD and antimicrobials.
Main Methods:
- The working group convened to analyze existing literature and clinical evidence.
- Discussions focused on identifying gaps in current knowledge regarding antibiotic use in ASCVD prevention.
- Expert consensus was sought to formulate recommendations for future research methodologies and collaborative frameworks.
Main Results:
- The evaluation indicated a need for further rigorous clinical trials to ascertain the efficacy of antimicrobial agents in ASCVD prevention.
- Specific trial designs were conceptualized, considering patient populations, intervention parameters, and outcome measures.
- The critical role of interdisciplinary collaboration was highlighted for enhancing the scope and impact of future research.
Conclusions:
- Additional well-designed clinical antibiotic trials are warranted to explore the potential of antimicrobial therapies in ASCVD prevention.
- Future research should incorporate innovative trial designs and foster robust collaborations among researchers, clinicians, and institutions.
- A collaborative approach is essential for efficiently answering complex research questions in this field.
Related Concept Videos
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease V: Interprofessional Care
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis III: Management
Atherosclerosis IV: Nursing Management
Peripheral Artery Disease III: Interprofessional Care

